As per our report, the global dermal fillers market size is expected to grow at a 6.67% CAGR during the forecast period. The market size is forecasted to worth USD 10.11 billion by 2026 and USD 7.32 billion in 2021. There has been a rapid increase in the use of dermal fillers in dermatology–aesthetic practice.
Dermal fillers are considered by many to be an efficient way to enhance facial aesthetics with minimal downtime quickly. Physicians must consider the individual characteristics of each patient and available filler when making treatment selections. While adverse events are rare, serious complications can result. The ability of the physician to handle rare adverse events and the ability to identify the etiology of the complication accurately ensures that the patient receives the best possible care. To prevent the number of adverse effects, the practitioner must choose the right product, perform the right procedure, and inject with skill.
Dermal filler is a soft tissue filler that helps to repair the skin by filling the underlying tissues. These dermal fillers are also called injectable implants and wrinkle fillers. There are two types of dermal fillers, which are absorbable and non-absorbable. These are manufactured from sugar molecules and compounds like hyaluronic acids and collagens.
The dermal filler technique is cost-efficient compare to surgical procedures available in the market. Dermal filler has applications other than aging, such as HIV-induced facial lipoatrophy, in the treatment of paralyzed vocal cords, enhancement of the dorsal area of the hand.
Y-O-Y growth in the usage of Hyaluronic acid (HA) among people is expected to drive the global dermal fillers market growth.
The key market players are working on new and more advanced techniques to improve the treatment and expand the product portfolio as the treatment lasts for 6 to 12 months, which is expected to drive the dermal filler market growth. There is an increasing demand for youth, and aesthetic facial skin is one of the market drivers.
The rising adoption of aesthetic (cosmetic) devices in developed countries is becoming more common, favoring global dermal fillers market growth.
The FDA recommends that all dermal filler packets be thoroughly inspected for authenticity. In March 2017, July 2018, and October 2018, the FDA became aware of counterfeit products being sold and used in the United States, reported by FDA. With growing awareness of cosmetic anti-aging processes and the rise in the prevalence of minimally invasive surgeries throughout the forecast period, the market is expected to grow lucratively. Moreover, the emergence of technologically advanced and user-friendly products coupled with other factors such as increasing social acceptance for aesthetic products and the expansion strategies of market players in emerging countries are expected to drive market growth over the coming years.
The growing elderly population across the world is another significant factor boosting the global dermal fillers market.
The growing geriatric population behaves as a rendering factor of high impact for the expansion of the industry. Increasing numbers of older people undergoing dermal filler therapy should increase business growth to restore lost volume and elevate sagging skin. According to WHO, there will be 1.5 billion people above 60 in 2050. For example, although France probably takes 150 years to adjust to a shift from 10% to 20% of the population over 60, Brazil, China, and India would take slightly less than 20 years. A growing number of facilities and professionals in developing countries. Due to growing awareness about dermal fillers, a government initiative in developing countries like India, China, Japan, etc. Increasing medical tourism, coupled with increasing consumer spending power.
The use of dermal fillers carries the same risks as any other medical procedure. It's important to be aware of their limitations and potential dangers. Infection, redness, swelling, pain, and tenderness in or under the skin (nodules or granulomas) may require injections, oral antibiotics, or surgical removal. High Cost of Aesthetic Surgeries to impede the dermal fillers Market Growth. Besides, the incidence of unregistered practitioners is expected to impact the dermal fillers market in the future negatively. The rising number of complications post events. Stringent regulatory procedures can hamper the market for dermal fillers. These are the restraining factor for the dermal fillers market.
Impact of COVID-19 on the global dermal fillers market:
Pharmaceuticals and biotech firms are working together with policymakers across the globe to resolve the outbreak of COVID-19, from promoting vaccine production to preparing for drug supply chain challenges. There are currently approximately 115 vaccine candidates and 155 molecules in the R&D pipeline. Also, widely used medications, such as hydroxychloroquine, have seen a dramatic increase in demand for COVID-19 treatment. Such high demand for these drugs has provided an enormous opportunity for producers of COVID-19 drug control medications, as many developing countries are short of these drugs. During the lockdown on the global front, many cosmetic facilities and clinics were shut down. The increasing number of coronaviruses reduces the number of cosmetic surgeries that negatively affect the market size of the dermal fillers. Three patients with dermal fillers have recently been confirmed to have had negative reactions to the Moderna COVID-19 vaccine.
Localized facial swelling occurred in two of these cases after vaccination, and lip angioedema occurred in one case two days after vaccination. After treatment with steroids and/or antihistamines, one of these cases was resolved. This will be noted in the FDA's prescribing records. In patients who received the Pfizer COVID-19 vaccine, no cases have been confirmed. Due to the need for vaccines and treatment drugs for COVID-19, the pharmaceutical and biotechnology industries are expected to see substantial growth in the future. Given these factors, COVID-19 is expected to have a major effect on the dermal filler market. The Aesthetic Society will continue to check for any further observed reactions in people who received the COVID-19 vaccine when using dermal fillers and will update these guidelines as needed.
Market Size Available
2020 to 2026
2021 to 2026
By Product, Therapeutic Area, and Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
North America, Europe, Asia Pacific, Latin America, Middle East & Africa
This market research report on the global dermal fillers market has been segmented and sub-segmented based on the product, therapeutic area, and region.
Dermal Fillers Market - By Product:
Based on the product, the biodegradable fillers segment had the largest market share of about 82% in 2020 and predicted it would continue the same trend in the coming years. It is due to the porous assets. The rise in the demand to improve the quality of the treatment procedures is escalating market growth.
The non-biodegradable segment is estimated to present a CAGR of 9.2% during the forecast period. These non-absorbable fillers outcomes can be seen for a period of 6-24months. The market postulate for non-absorbable will show sufficient growth in the forthcoming years.
Dermal Fillers Market Analysis - By Therapeutic Area:
Based on the therapeutic area, in 2020, the deep facial lines, wrinkles are the leading segments in the market. These two segments are projected to grow at a healthy rate during the forecast period. Growing older people population across the globe and increasing demand for cosmetic surgeries are propelling the need of the market. Also, the adoption of a sedentary lifestyle and changes in food habits are surging the market's growth.
Dermal Fillers Market Analysis - By Region:
Regionally, North America accounted for the largest share in the global dermal filler market in 2020. The increasing demand for non-invasive procedures is boosting market growth. The need for a less complex, painful, and long-lasting process drives the market in the North American market. The dermal filler comes under the U.S. FDA, which has reduced the risk factor related to the overuse of chemicals. This has increased awareness about the advantage of dermal fillers, which will propel the growth rate of the dermal filler market. There is an increasing number of aged people in this region due to the excellent mortality rate, and the low cost of the procedure is boosting the market growth in this region.
The European area has the second-largest share in the global dermal filler market. The rising geriatric population in this region is promoting the growth of the market. The more advanced technique and the ongoing clinical trial are propelling the market growth in this region. With the increasing geriatric rate and availability of procedures at low cost, there are 140 filters in the market, escalating the market. The fillers are non-prescription medicine in Europe which is another major factor leading to the market's growth.
KEY MARKET PARTICIPANTS:
Companies like Allergan Inc., AQTIS Medical, Bioha Laboratories, Suneva Medical, Galderma, Merz Aesthetics, Cynosure, Syneron, and Cytophil Inc. are playing a leading role in the global dermal fillers market.
RECENT MARKET DEVELOPMENTS:
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Absorbable or Biodegradable
5.1.3 Non-Absorbable or Non-Biodegradable
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Therapeutic Area
5.2.3 Deep Facial Lines
5.2.4 Sagging Skin
5.2.6 Y-o-Y Growth Analysis, By Therapeutic Area
5.2.7 Market Attractiveness Analysis, By Therapeutic Area
5.2.8 Market Share Analysis, By Therapeutic Area
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Product
220.127.116.11 By Therapeutic Area
6.1.4 Market Attractiveness Analysis
18.104.22.168 By Geographical Area
22.214.171.124 By Product
126.96.36.199 By Therapeutic Area
6.1.5 Market Share Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Product
220.127.116.11 By Therapeutic Area
6.2 North America
6.1.2 United States
6.3.6 South Korea
6.5 Latin America
6.4.5 Rest of Latin America
6.6 Middle East & Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Allergan Inc.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 AQTIS Medical
8.3 Bioha Laboratories
8.4 Suneva Medical
8.6 Merz Aesthetics
8.9 Cytophil Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures